Public Profile

Shenhua Pharmaceutical

Shenhua Pharmaceutical Co., Ltd., commonly referred to as Shenhua Pharma, is a prominent player in the pharmaceutical industry, headquartered in China (CN). Established in the early 2000s, the company has rapidly expanded its operations across major regions in Asia, focusing on the development, manufacturing, and distribution of high-quality pharmaceutical products. Shenhua Pharma is renowned for its innovative approach to drug formulation, particularly in the fields of oncology, cardiology, and infectious diseases. The company’s commitment to research and development has led to several key milestones, including the launch of unique generics and proprietary medications that address unmet medical needs. With a strong market position, Shenhua Pharma has garnered recognition for its contributions to healthcare, consistently striving to enhance patient outcomes through effective and affordable treatments.

DitchCarbon Score

How does Shenhua Pharmaceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

0

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

6

Industry Benchmark

Shenhua Pharmaceutical's score of 0 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.

26%

Shenhua Pharmaceutical's reported carbon emissions

Shenhua Pharmaceutical, headquartered in CN, currently does not have publicly available data regarding its carbon emissions, including specific figures for Scope 1, 2, or 3 emissions. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This lack of information suggests that the company may still be in the early stages of formalising its climate commitments or reporting practices. As the pharmaceutical industry increasingly prioritises sustainability, it is essential for Shenhua Pharmaceutical to establish clear emissions data and reduction strategies to align with global climate goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Shenhua Pharmaceutical's primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Shenhua Pharmaceutical is headquartered in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Shenhua Pharmaceutical is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Health Services

Synthon

NL
Health Services
Updated 11 days ago

Comfort Foods Co-Packing & Processing

US
Health Services
Updated 11 days ago

VELOCITY CLINICAL RESEARCH

US
Health Services
Updated 11 days ago

Wylde About Health Inc

CA
Health Services
Updated 3 days ago

LEVACHEM

CN
Health Services
Updated 11 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers